ASHLEY MCCLURE: Open Payments
NPI 1144093543 · MEADVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,203 in 65 payments from 16 companies in 2025. Trend: 2023 $48 · 2024 $601 · 2025 $1,203
Food & beverage: $1,148Education: $55
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 17 | $216 |
| Novartis Pharmaceuticals Corporation | 14 | $198 |
| GENZYME CORPORATION | 8 | $159 |
| ABBVIE INC. | 6 | $126 |
| Janssen Biotech, Inc. | 3 | $95 |
| Galderma Laboratories, L.P. | 1 | $88 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $40 |
| Incyte Corporation | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
Products named: Bimzelx, DUPIXENT, SKYRIZI, COSENTYX, TREMFYA, NEMLUVIO, LIBTAYO, SILIQ.
Industry payments across PA — which companies pay providers there.
